REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharmablock Sciences (Nanjing), Inc. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pharmablock Sciences (Nanjing), Inc. Profile Updated: November 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

PharmaBlock Sciences (Nanjing), Inc. is a provider of chemistry products and services. Its business includes a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was founded in 2006 and is headquartered in Nanjing City, China.

Headquarters
No. 10, Xuefu Road, Jiangbei New District, Nanjing, Jiangsu Province
Nanjing; Jiangsu; Postal Code: 210032

Contact Details: Purchase the Pharmablock Sciences (Nanjing), Inc. report to view the information.

Website: http://https://www.pharmablock.com

Basic Information
Total Employees:
Purchase the Pharmablock Sciences (Nanjing), Inc. report to view the information.
Outstanding Shares:
Purchase the Pharmablock Sciences (Nanjing), Inc. report to view the information.
Registered Capital:
Purchase the Pharmablock Sciences (Nanjing), Inc. report to view the information.
Financial Auditors:
Purchase the Pharmablock Sciences (Nanjing), Inc. report to view the information.
Incorporation Date:
December 26, 2006
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
20.74%
Purchase this report to view the information.
2.93%
Purchase this report to view the information.
2.79%
Purchase this report to view the information.
2.71%
Purchase this report to view the information.
2.05%
Subsidiaries
Nanjing Anakang Biological Technology Co., Ltd.
100%
Nanjing Furun CapitaLand Biological Medicine Co., Ltd.
100%
Nanjing Maisheng Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Pharmablock Sciences (Nanjing), Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-12.67%▼
Total operating revenue
-6.98%▼
Operating profit (EBIT)
-0.29%▼
Net Profit (Loss) for the Period
-14.45%▼
Total assets
-5.77%▼
Total equity
3.25%▲
Operating Profit Margin (ROS)
1.51%▲
Net Profit Margin
-0.25%▼
Return on Equity (ROE)
-0.94%▼
Debt to Equity Ratio
-12.1%▼
Quick Ratio
0.06%▲
Cash Ratio
-0.66%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Guizhou Sanli Pharmaceutical Co.,Ltd
 
Huaren Pharmaceutical Co.,Ltd.
Hunan Fangsheng Pharmaceutical Co.,Ltd
 
Zhejiang Anglikang Pharmaceutical Co.,Ltd.
Shanghai Kaibao Pharmaceutical Co.,Ltd
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo